晚期内皮祖细胞对血管新生影响的研究进展  

The impact of late endothelial progenitor cells on angiogenesis

作　　者：杨晶晶[1] 程江涛[2] 李志海[1] 

机构地区：[1]河南中医学院第一附属医院心内科,河南郑州450000 [2]河南省人民医院心内科3区,河南郑州450003

出　　处：《中国现代医生》2016年第20期165-168,共4页China Modern Doctor

基　　金：国家自然科学基金资助项目(81273948)

摘　　要：内皮祖细胞在体外形成新生血管的能力,正在成为一种新颖的治疗缺血性疾病的方案。目前,认为内皮祖细胞分为早期内皮祖细胞与晚期内皮祖细胞两种,且晚期内皮祖细胞促进新生血管的能力更强。本文总结了近年来内皮祖细胞的研究进展,并对其在肺动脉高压中的潜在治疗作用进行了讨论。The neovascularization of the EPCs in vitro is becoming a novel treatment of ischemic diseases. Currently it accepted that EPCs include early endothelial progenitor cells and late endothelial progenitor, and the ability to promote angiogenesis of late endothelial progenitor cells is stronger than early endothelial progenitor cells. This paper summarized the research progress of endothelial progenitor cells in recent years, and discussed it＇s potential therapeutic role in pulmonary hypertension.

关 键 词：内皮祖细胞 血管新生 内皮细胞 肺动脉高压 

分 类 号：R285.5[医药卫生—中药学]